AP NEWS

Seres Therapeutics: 3Q Earnings Snapshot

November 8, 2018

CAMBRIDGE, Mass. (AP) _ Seres Therapeutics Inc. (MCRB) on Thursday reported a loss of $21.9 million in its third quarter.

The Cambridge, Massachusetts-based company said it had a loss of 54 cents per share.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 57 cents per share.

The drug developer posted revenue of $9.1 million in the period.

Seres Therapeutics shares have decreased 20 percent since the beginning of the year. The stock has decreased 16 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MCRB at https://www.zacks.com/ap/MCRB

AP RADIO
Update hourly